RecruitingPhase 2

Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder

Canada50 participantsStarted 2022-09-22

Plain-language summary

This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.

Who can participate

Age range9 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges * Able to participate in rTMS Exclusion Criteria: * Children with autism spectrum disorder but no co-morbid self-regulation disorders. * Children with contraindications to TMS (history of seizures, family history of seizures, metal implants) * Co-existing neurological conditions (epilepsy, stroke, etc.)

What they're measuring

Recruitment

Timeframe: Weeks 1-18

Attrition

Timeframe: Weeks 1-18

Adherence

Timeframe: Weeks 1-18

Blinding success

Timeframe: Weeks 1-18

Trial details

NCT IDNCT05235919

SponsorHolland Bloorview Kids Rehabilitation Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02

Contact for this trial

Deryk Beal, PhD

416-425-6220 dbeal@hollandbloorview.ca

View on ClinicalTrials.gov More Autism Spectrum Disorder trials